Latest GLENVIEW CAPITAL MANAGEMENT, LLC Stock Portfolio
$5.49Billion | No. of Holdings #42
GLENVIEW CAPITAL MANAGEMENT, LLC Performance
2026 Q2+19.01%
YTD+11.07%
2025+16.24%
About GLENVIEW CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings
On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, GLENVIEW CAPITAL MANAGEMENT, LLC reported an equity portfolio of $5.5 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of GLENVIEW CAPITAL MANAGEMENT, LLC are GPN, CVS, THC. The fund has invested 11.8% of it's portfolio in GLOBAL PMTS INC and 9.1% of portfolio in CVS HEALTH CORP. <br><br> The fund managers got completely rid off DXC TECHNOLOGY CO (DXC), ZOOMINFO TECHNOLOGIES INC (ZI) and US FOODS HLDG CORP (USFD) stocks. They significantly reduced their stock positions in BIO-TECHNE CORP (TECH), APPLIED MATLS INC (AMAT) and DIGITALOCEAN HLDGS INC (DOCN). GLENVIEW CAPITAL MANAGEMENT, LLC opened new stock positions in AGILENT TECHNOLOGIES INC (A), ELI LILLY & CO (LLY) and MKS INC. (MKSI). The fund showed a lot of confidence in some stocks as they added substantially to DANAHER CORP DEL (DHR), META PLATFORMS INC (META) and THERMO FISHER SCIENTIFIC INC (TMO).
GLENVIEW CAPITAL MANAGEMENT, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$5.49Billion
as of Aug 14, 2026GLENVIEW CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that GLENVIEW CAPITAL MANAGEMENT, LLC made a return of 19.01% in the last quarter. In trailing 12 months, it's portfolio return was 24.34%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| agilent technologies inc | 261,614,000 |
| eli lilly & co | 69,292,300 |
| mks inc. | 43,827,000 |
| stmicroelectronics n v | 41,942,900 |
| abbvie inc | 37,472,500 |
| astrazeneca plc | 34,943,000 |
| elevance health inc formerly | 25,755,800 |
| microchip technology inc. | 24,220,600 |
New stocks bought by GLENVIEW CAPITAL MANAGEMENT, LLC
Additions
| Ticker | % Inc. |
|---|---|
| danaher corp del | 633 |
| meta platforms inc | 190 |
| thermo fisher scientific inc | 150 |
| national vision hldgs inc | 98.04 |
| baker hughes company | 62.52 |
| genius sports limited | 57.64 |
| tenet healthcare corp | 46.62 |
| global pmts inc | 40.03 |
Additions to existing portfolio by GLENVIEW CAPITAL MANAGEMENT, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| bio-techne corp | -68.7 |
| applied matls inc | -66.94 |
| digitalocean hldgs inc | -66.08 |
| advanced micro devices inc | -54.15 |
| centene corp del | -41.31 |
| cvs health corp | -41.14 |
| element solutions inc | -38.93 |
| onto innovation inc | -31.34 |
GLENVIEW CAPITAL MANAGEMENT, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| zoominfo technologies inc | -95,113,300 |
| dxc technology co | -111,821,000 |
| myriad genetics inc | -24,353,900 |
| lionsgate studios corp | -26,648,500 |
| surgery partners inc | -21,456,000 |
| zillow group inc | -32,676,500 |
| intel corp | -17,630,200 |
| us foods hldg corp | -35,409,300 |
GLENVIEW CAPITAL MANAGEMENT, LLC got rid off the above stocks
Sector Distribution
GLENVIEW CAPITAL MANAGEMENT, LLC has about 53.7% of it's holdings in Healthcare sector.
- Healthcare
- Industrials
- Technology
- Consumer Cyclical
- Others
- Communication Services
| Sector | % |
|---|---|
| Healthcare | 53.7 |
| Industrials | 14.3 |
| Technology | 13 |
| Consumer Cyclical | 9 |
| Others | 4.5 |
| Communication Services | 4 |
Market Cap. Distribution
GLENVIEW CAPITAL MANAGEMENT, LLC has about 89.6% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- MEGA-CAP
- UNALLOCATED
- SMALL-CAP
- MID-CAP
| Category | % |
|---|---|
| LARGE-CAP | 65.7 |
| MEGA-CAP | 23.9 |
| UNALLOCATED | 4.5 |
| SMALL-CAP | 3.6 |
| MID-CAP | 1.9 |
Stocks belong to which Index?
About 74.2% of the stocks held by GLENVIEW CAPITAL MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.
- S&P 500
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| S&P 500 | 68.8 |
| Others | 25.8 |
| RUSSELL 2000 | 5.4 |
GLENVIEW CAPITAL MANAGEMENT, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of GLENVIEW CAPITAL MANAGEMENT, LLC
GLENVIEW CAPITAL MANAGEMENT, LLC has 42 stocks in it's portfolio. About 58.4% of the portfolio is in top 10 stocks. EYE proved to be the most loss making stock for the portfolio. CVS was the most profitable stock for GLENVIEW CAPITAL MANAGEMENT, LLC last quarter.
$5.01BTotal Value
53.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Agilent Technologies Inc GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Agilent Technologies Inc over time | 4.76% | 1,969,540 | $261.61M 4.76% | Newnew position | |
 Abbvie Inc Abbvie IncABBV GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Abbvie Inc over time | 0.68% | 148,913 | $37.47M 0.68% | Newnew position | |
 Akamai Technologies Inc GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Akamai Technologies Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Applied Matls Inc GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Applied Matls Inc over time | 0.86% | 65,201 | $47.14M 0.86% | 66.94%decreased 66.94 percentreduced | |
 Advanced Micro Devices Inc GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Advanced Micro Devices Inc over time | 3.16% | 298,410 | $173.35M 3.16% | 54.15%decreased 54.15 percentreduced | |
 Amazon Com Inc Amazon Com IncAMZN GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Amazon Com Inc over time | 5.52% | 1,271,690 | $303.09M 5.52% | 20.05%increased 20.05 percentadded | |
 Elevance Health Inc Formerly GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Elevance Health Inc Formerly over time | 0.47% | 66,599 | $25.76M 0.47% | Newnew position | |
 Butterfly Network Inc GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Butterfly Network Inc over time | 2.2% | 14,335,100 | $120.70M 2.2% | 0%unchanged 0 percentunchanged | |
 Biogen Inc Biogen IncBIIB GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Biogen Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Baker Hughes Company GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Baker Hughes Company over time | 0.5% | 493,519 | $27.39M 0.5% | 62.52%increased 62.52 percentadded | |
 Bausch Plus Lomb Corp GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Bausch Plus Lomb Corp over time | 0.58% | 1,918,150 | $31.76M 0.58% | 0.4%increased 0.4 percentadded | |
 Bruker Corp Bruker CorpBRKR GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Bruker Corp over time | 0.28% | 252,169 | $15.18M 0.28% | Newnew position | |
 Boston Scientific Corp GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Boston Scientific Corp over time | 0.09% | 113,096 | $4.83M 0.09% | Newnew position | |
 Cardinal Health Inc GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Cardinal Health Inc over time | 0.08% | 18,018 | $4.28M 0.08% | Newnew position | |
 The Cigna Group GLENVIEW CAPITAL MANAGEMENT, LLC's holding in The Cigna Group over time | 2.07% | 412,223 | $113.64M 2.07% | 17.36%decreased 17.36 percentreduced | |
 Centene Corp Del GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Centene Corp Del over time | 2.2% | 1,886,060 | $121.07M 2.2% | 41.31%decreased 41.31 percentreduced | |
 Cisco Sys Inc Cisco Sys IncCSCO GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Cisco Sys Inc over time | 0.88% | 413,332 | $48.55M 0.88% | 21.63%increased 21.63 percentadded | |
 Cvs Health Corp GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Cvs Health Corp over time | 9.09% | 4,824,800 | $499.13M 9.09% | 41.14%decreased 41.14 percentreduced | |
 Danaher Corp Del GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Danaher Corp Del over time | 3.98% | 1,145,980 | $218.29M 3.98% | 633.31%increased 633.31 percentadded | |
 Dicks Sporting Goods Inc GLENVIEW CAPITAL MANAGEMENT, LLC's holding in Dicks Sporting Goods Inc over time | 1.66% | 401,067 | $90.97M 1.66% | 34.18%increased 34.18 percentadded | |